PortAuthority teams with Blue Coat

PortAuthority, which has its R&D center in Ra'anana, said the deal would give it access to tens of thousands of Blue Coat customers.

By AVI KRAWITZ
August 28, 2006 08:21

 
X

Dear Reader,
As you can imagine, more people are reading The Jerusalem Post than ever before. Nevertheless, traditional business models are no longer sustainable and high-quality publications, like ours, are being forced to look for new ways to keep going. Unlike many other news organizations, we have not put up a paywall. We want to keep our journalism open and accessible and be able to keep providing you with news and analyses from the frontlines of Israel, the Middle East and the Jewish World.

As one of our loyal readers, we ask you to be our partner.

For $5 a month you will receive access to the following:

  • A user experience almost completely free of ads
  • Access to our Premium Section
  • Content from the award-winning Jerusalem Report and our monthly magazine to learn Hebrew - Ivrit
  • A brand new ePaper featuring the daily newspaper as it appears in print in Israel

Help us grow and continue telling Israel’s story to the world.

Thank you,

Ronit Hasin-Hochman, CEO, Jerusalem Post Group
Yaakov Katz, Editor-in-Chief

UPGRADE YOUR JPOST EXPERIENCE FOR 5$ PER MONTH Show me later

Israeli-founded PortAuthority Technologies has signed a partnership agreement with US-based secure content provider Blue Coat Systems to create an integrated security solution to prevent costly information leaks and ensure regulatory compliance, PortAuthority said Sunday. PortAuthority, which has its R&D center in Ra'anana, said the deal would give it access to tens of thousands of Blue Coat customers. The application will combine Blue Coat's SG appliance with PortAuthority's Information Leak Prevention appliance to enable companies to accurately prevent information leaks over encrypted and non-secure Web communications, the companies said.

Join Jerusalem Post Premium Plus now for just $5 and upgrade your experience with an ads-free website and exclusive content. Click here>>

Related Content

The Teva Pharmaceutical Industries
April 30, 2015
Teva doubles down on Mylan, despite rejection

By GLOBES, NIV ELIS